Project description
MRI contrast agents may soon be able to treat conditions in addition to diagnosing them
Magnetic resonance imaging (MRI) harnesses the body's natural magnetic properties to produce detailed images of organs and tissues. Although originally intended to be used without contrast agents, research showed that such agents enhance sensitivity and/or selectivity, improving the accuracy of diagnoses in many conditions. There are now many different contrast agents available, largely based on which tissues or structures are of interest. However, increasing evidence suggests some of these may accumulate in tissues with repeated use and a need exists for alternative solutions. NOVA-MRI is harnessing the power of smart nanoparticles and their functionalisation. It could pave the way to novel contrast agents that can carry therapeutics to a target site and facilitate controlled release and treatment.
Fields of science
Programme(s)
Coordinator
2333 ZA Leiden
Netherlands
See on map
Participants (11)
62032 Camerino
See on map
40225 Dusseldorf
See on map
20009 San Sebastian
See on map
Participation ended
6525 XZ Nijmegen
CB2 1TN Cambridge
See on map
08007 Barcelona
See on map
EH8 9YL Edinburgh
See on map
2573 HT 'S-gravenhage
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
50931 Koln
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
0349 Oslo
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
40597 Dusseldorf
See on map